Implementation of New Exercise Protocols in Cardiac Rehabilitation.

NCT ID: NCT07161219

Last Updated: 2025-09-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-01

Study Completion Date

2029-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

* Primary Objective: To evaluate the effects of complementary exercise protocols in cardiac rehabilitation (CR), such as inspiratory muscle training (IMT), by assessing inspiratory muscle strength.
* Secondary Objectives: To assess functional capacity, quality of life (QoL), and pulmonary function.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Diseases Cardiac Disease Inspiratory Muscle Training

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

randomized control trial
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control group

Group Type NO_INTERVENTION

No interventions assigned to this group

intervention group

Group Type EXPERIMENTAL

inspiratory muscle training

Intervention Type DEVICE

inspiratory muscle training for intervention group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

inspiratory muscle training

inspiratory muscle training for intervention group

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Patient meeting the conditions of the permanent life support agreement following hospitalization for a cardiac condition such as: acute myocardial infarction; coronary surgery; therapeutic percutaneous endovascular intervention on the coronary arteries, under medical imaging guidance; therapeutic percutaneous endovascular intervention on the heart, under medical imaging guidance; surgery for congenital or acquired heart malformation; surgery for valvular lesion; heart transplantation; resistant angina (to be specified by detailed history, medical history, and technical examinations, justifying multidisciplinary care); cardiomyopathy with left ventricular dysfunction (to be specified by detailed history, medical history, and technical examinations, justifying multidisciplinary care).

* Patient aged between 18 and 80 years.
* Patient capable of giving informed consent.
* Patient registered for permanent life support at the CuSL.
* Patient capable of understanding instructions in French. - Patient with prior medical consent and clinically stable.

Exclusion Criteria

* \- Minor (\<18 years old).
* Pregnant woman.
* Patient unable to provide informed consent.
* Patient with cognitive, neurological, or orthopedic limitations.
* Patient with mobility or musculoskeletal difficulties incompatible with physical activity.
* Clinical instability.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dayez Martin

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sabrina Fernandez, PT

Role: CONTACT

027649938

Martin Dayez, PT

Role: CONTACT

027646043

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

à compléter

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.